Biocon declines on reporting 90% fall in Q1 consolidated net profit

08 Aug 2025 Evaluate

Biocon is currently trading at Rs. 354.25, down by 10.35 points or 2.84% from its previous closing of Rs. 364.60 on the BSE.

The scrip opened at Rs. 358.55 and has touched a high and low of Rs. 365.70 and Rs. 353.70 respectively. So far 114500 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 405.90 on 18-Jul-2025 and a 52 week low of Rs. 290.80 on 03-Mar-2025.

Last one week high and low of the scrip stood at Rs. 386.60 and Rs. 353.60 respectively. The current market cap of the company is Rs. 47896.72 crore.

The promoters holding in the company stood at 54.45%, while Institutions and Non-Institutions held 28.86% and 16.68% respectively.

Biocon has reported net loss at Rs 8.30 crore for first quarter ended June 30, 2025 (Q1FY26) as compared to net profit Rs 0.90 crore for the same quarter in the previous year. However, total income of the company increased by 8.31% at Rs 598.40 crore for Q1FY26 as compared to Rs 552.50 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 89.65% fall in its net profit at Rs 89.20 crore for Q1FY26 as compared to Rs 861.80 crore for the same quarter in the previous year. The total income of the company decreased by 11.95% at Rs 4,021.60 crore for Q1FY26 as compared to Rs 4,567.40 crore for the corresponding quarter previous year.


Biocon Share Price

392.55 4.30 (1.11%)
05-Dec-2025 15:04 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.15
Dr. Reddys Lab 1275.50
Cipla 1521.80
Zydus Lifesciences 931.80
Lupin 2100.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×